Latest Articles

Publication Date
High AMH Levels Tied to Increased Risk of Miscarriage in Overweight Women: Study Finds - Medical Dialogues

High AMH Levels Tied to Increased Risk of Miscarriage in Overweight Women: Study Finds Medical Dialogues

Published: March 4, 2025, 3 p.m.
Dolly Parton revealed ‘dark’ & heartbreaking reason she never had children with husband Carl Dean in 58-year marriage - NewsBreak

Dolly Parton revealed ‘dark’ & heartbreaking reason she never had children with husband Carl Dean in 58-year marriage NewsBreak

Published: March 4, 2025, 2:45 p.m.
Emmerdale star Kathryn Apanowicz dies aged 64 - Her.ie

Emmerdale star Kathryn Apanowicz dies aged 64 Her.ie

Published: March 4, 2025, 11:20 a.m.
A Rare Case of Endometrial Adenosarcoma and Its Management: A Case Report and Literature Review - Cureus

A Rare Case of Endometrial Adenosarcoma and Its Management: A Case Report and Literature Review Cureus

Published: March 3, 2025, 5:57 p.m.
Shining Light On Endometriosis - Mirage News

Shining Light On Endometriosis Mirage News

Published: March 2, 2025, 10:16 p.m.
‘No stage 5’: Tauranga mum’s cancer fight - SunLive

‘No stage 5’: Tauranga mum’s cancer fight SunLive

Published: March 2, 2025, 4 p.m.
‘No stage 5’: Tauranga mum’s cancer fight - web2.sunlive.co.nz

‘No stage 5’: Tauranga mum’s cancer fight web2.sunlive.co.nz

Published: March 2, 2025, 4 p.m.
The dos and don’ts of contacting employees on sick leave - People Management Magazine

The dos and don’ts of contacting employees on sick leave People Management Magazine

Published: Feb. 28, 2025, 11:14 a.m.
Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis - BioMed Central

Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis BioMed Central

Published: Feb. 28, 2025, 10:47 a.m.
Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis - bmcwomenshealth.biomedcentral.com

Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis bmcwomenshealth.biomedcentral.com

Published: Feb. 28, 2025, 10:47 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!